TOKYO -- Moderna, the U.S. pharmaceutical that brought mRNA technology to the fight against COVID-19, is considering building a factory in Japan to produce its vaccines, CEO Stephane Bancel told Nikkei on Wednesday. Construction would start if the Japanese government signs a long-term deal, perhaps 10 years, during which it would be obligated to buy vaccines.
COVID vaccines
Moderna looks to build COVID vaccine plant in Japan, CEO says
Pharmaceutical first needs government to agree to long-term purchases of shots
Moderna CEO Stephane Bancel on Sept. 14 says his vaccine maker wants the same kind of deal with the Japanese government that it has with Canada, the U.K. and Australia. (Photo by Suzu Takahashi)
Read Next
Latest on COVID vaccines
